Oxford Astrazeneca

Rediff.com » News » Oxford Astrazeneca

News for Oxford Astrazeneca

News
Business

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

The United Kingdom on Monday began rolling out the Oxford/AstraZeneca vaccine against COVID-19, becoming the first nation to inoculate people with the cheaper and easy-to-handle jab outside of......

Oxford-AstraZeneca Covid jab faces legal threat in UK over side effects: Report

The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal challenge in the high court in London, a UK media report said on......

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday said that clinical trials for their coronavirus vaccine have resumed in the United Kingdom after the Medicines Health......

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved for human use by the United Kingdom’s independent regulator.......

Pfizer, AstraZeneca vaccines protect against Delta variant: Study

The Delta variant of coronavirus, first identified in India, doubles the risk of hospitalisation compared with the Alpha variant first found in the United Kingdom, but Pfizer and AstraZeneca......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

'We will price Covid vaccine below Rs 1,000'

'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......

Indian economy to rebound with 8.9% growth in FY22

Indian economy is likely to rebound with an 8.9 per cent growth in the fiscal year beginning April 2021 after economic activity showed significant improvement in the last quarter, IHS Markit said......

Serum Institute to provide Covid vaccine at Rs 250 a dose

Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Sensex rallies 308 points to end at lifetime high

ONGC was the top gainer in the Sensex pack, rising around 4 per cent, followed by TCS, HCL Tech, Tech Mahindra, Infosys, M&M, HUL and L&T. On the other hand, Kotak Bank, Bajaj Finance, Asian......

Oxford Astrazeneca

News for Oxford Astrazeneca

UK becomes world's first to roll out Oxford/AstraZeneca vaccine

Oxford-AstraZeneca Covid jab faces legal threat in UK over side effects: Report

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Pfizer, AstraZeneca vaccines protect against Delta variant: Study

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

'We will price Covid vaccine below Rs 1,000'

Indian economy to rebound with 8.9% growth in FY22

Serum Institute to provide Covid vaccine at Rs 250 a dose

Sensex rallies 308 points to end at lifetime high

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS